205 related articles for article (PubMed ID: 28807916)
21. Identification of Antinorovirus Genes in Human Cells Using Genome-Wide CRISPR Activation Screening.
Orchard RC; Sullender ME; Dunlap BF; Balce DR; Doench JG; Virgin HW
J Virol; 2019 Jan; 93(1):. PubMed ID: 30305350
[TBL] [Abstract][Full Text] [Related]
22. Antiviral activity and mode of action studies of ribavirin and mycophenolic acid against orthopoxviruses in vitro.
Smee DF; Bray M; Huggins JW
Antivir Chem Chemother; 2001 Nov; 12(6):327-35. PubMed ID: 12018677
[TBL] [Abstract][Full Text] [Related]
23. Antiviral activity of Schizonepeta tenuifolia Briquet against noroviruses via induction of antiviral interferons.
Ng YC; Kim YW; Lee JS; Lee SJ; Jung Song M
J Microbiol; 2018 Sep; 56(9):683-689. PubMed ID: 30141161
[TBL] [Abstract][Full Text] [Related]
24. FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in
Ianiri G; Applen Clancey S; Lee SC; Heitman J
mBio; 2017 Oct; 8(5):. PubMed ID: 29066552
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of action of ribavirin in a novel hepatitis C virus replication cell system.
Mori K; Ikeda M; Ariumi Y; Dansako H; Wakita T; Kato N
Virus Res; 2011 Apr; 157(1):61-70. PubMed ID: 21320556
[TBL] [Abstract][Full Text] [Related]
26. The structure of inosine 5'-monophosphate dehydrogenase and the design of novel inhibitors.
Sintchak MD; Nimmesgern E
Immunopharmacology; 2000 May; 47(2-3):163-84. PubMed ID: 10878288
[TBL] [Abstract][Full Text] [Related]
27. Mycophenolic acid potently inhibits rotavirus infection with a high barrier to resistance development.
Yin Y; Wang Y; Dang W; Xu L; Su J; Zhou X; Wang W; Felczak K; van der Laan LJ; Pankiewicz KW; van der Eijk AA; Bijvelds M; Sprengers D; de Jonge H; Koopmans MP; Metselaar HJ; Peppelenbosch MP; Pan Q
Antiviral Res; 2016 Sep; 133():41-9. PubMed ID: 27468950
[TBL] [Abstract][Full Text] [Related]
28. Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.
Neuberger M; Sommerer C; Böhnisch S; Metzendorf N; Mehrabi A; Stremmel W; Gotthardt D; Zeier M; Weiss KH; Rupp C
Clin Res Hepatol Gastroenterol; 2020 Sep; 44(4):543-550. PubMed ID: 31924555
[TBL] [Abstract][Full Text] [Related]
29. [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice].
Naito T
Yakugaku Zasshi; 2010 Dec; 130(12):1695-700. PubMed ID: 21139397
[TBL] [Abstract][Full Text] [Related]
30. Biochemical differences among four inosinate dehydrogenase inhibitors, mycophenolic acid, ribavirin, tiazofurin, and selenazofurin, studied in mouse lymphoma cell culture.
Lee HJ; Pawlak K; Nguyen BT; Robins RK; Sadée W
Cancer Res; 1985 Nov; 45(11 Pt 1):5512-20. PubMed ID: 2865005
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenetics of the mycophenolic acid targets inosine monophosphate dehydrogenases IMPDH1 and IMPDH2: gene sequence variation and functional genomics.
Wu TY; Peng Y; Pelleymounter LL; Moon I; Eckloff BW; Wieben ED; Yee VC; Weinshilboum RM
Br J Pharmacol; 2010 Dec; 161(7):1584-98. PubMed ID: 20718729
[TBL] [Abstract][Full Text] [Related]
32. A broad influenza virus inhibitor acting via IMP dehydrogenase and in synergism with ribavirin.
Vanderlinden E; Marchand A; Van Berwaer R; van Dam W; Arzel P; Klaassen H; Persoons L; Chaltin P; Naesens L
Antiviral Res; 2021 Dec; 196():105208. PubMed ID: 34793841
[TBL] [Abstract][Full Text] [Related]
33. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
Vethe NT; Bremer S; Bergan S
Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
[TBL] [Abstract][Full Text] [Related]
34. Nonnucleoside inhibitors of norovirus RNA polymerase: scaffolds for rational drug design.
Eltahla AA; Lim KL; Eden JS; Kelly AG; Mackenzie JM; White PA
Antimicrob Agents Chemother; 2014 Jun; 58(6):3115-23. PubMed ID: 24637690
[TBL] [Abstract][Full Text] [Related]
35. Antiviral activity of nucleoside analogues against norovirus.
Costantini VP; Whitaker T; Barclay L; Lee D; McBrayer TR; Schinazi RF; Vinjé J
Antivir Ther; 2012; 17(6):981-91. PubMed ID: 22910194
[TBL] [Abstract][Full Text] [Related]
36. Antiviral activity of a small molecule deubiquitinase inhibitor occurs via induction of the unfolded protein response.
Perry JW; Ahmed M; Chang KO; Donato NJ; Showalter HD; Wobus CE
PLoS Pathog; 2012; 8(7):e1002783. PubMed ID: 22792064
[TBL] [Abstract][Full Text] [Related]
37. Induction of cell differentiation in melanoma cells by inhibitors of IMP dehydrogenase: altered patterns of IMP dehydrogenase expression and activity.
Kiguchi K; Collart FR; Henning-Chubb C; Huberman E
Cell Growth Differ; 1990 Jun; 1(6):259-70. PubMed ID: 1980599
[TBL] [Abstract][Full Text] [Related]
38. A Novel Class of Norovirus Inhibitors Targeting the Viral Protease with Potent Antiviral Activity In Vitro and In Vivo.
Van Dycke J; Dai W; Stylianidou Z; Li J; Cuvry A; Roux E; Li B; Rymenants J; Bervoets L; de Witte P; Liu H; Neyts J; Rocha-Pereira J
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578432
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of norovirus replication by the nucleoside analogue 2'-C-methylcytidine.
Rocha-Pereira J; Jochmans D; Dallmeier K; Leyssen P; Cunha R; Costa I; Nascimento MS; Neyts J
Biochem Biophys Res Commun; 2012 Nov; 427(4):796-800. PubMed ID: 23063849
[TBL] [Abstract][Full Text] [Related]
40. Advances Toward a Norovirus Antiviral: From Classical Inhibitors to Lethal Mutagenesis.
Thorne L; Arias A; Goodfellow I
J Infect Dis; 2016 Feb; 213 Suppl 1(Suppl 1):S27-31. PubMed ID: 26744429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
